{"id":"W2109381544","doi":"10.1093/annonc/mdu009","title":"Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Cambridge Memorial Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Everolimus; Discontinuation; Adverse effect; Exemestane; Internal medicine; Pneumonitis; Placebo; Population; Breast cancer; Incidence (geometry); Hazard ratio; Clinical endpoint; Randomized controlled trial; Oncology; Cancer; Surgery; Confidence interval; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002084088,0.0001994698,0.0004584587,0.00006429349,0.00002745645,0.000001176535,0.0001936606,0.0002602731,0.00003929541],"category_scores_gemma":[0.00003779749,0.0001794726,0.00002999544,0.0001386222,0.0002566715,0.00001709897,0.0001066499,0.0001350039,0.000004198215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005684791,"about_ca_system_score_gemma":0.0002750068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003033225,"about_ca_topic_score_gemma":0.0001281845,"domain_scores_codex":[0.9986021,0.000202471,0.0003715068,0.0003933958,0.0001423617,0.00028818],"domain_scores_gemma":[0.9989057,0.0000783426,0.0003808758,0.0002525476,0.000268883,0.0001136521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004180945,0.0002845393,0.009234478,0.00001240382,0.000263286,0.000005001819,0.0006290313,0.0005044623,0.9721571,0.000015583,0.0002138977,0.01249923],"study_design_scores_gemma":[0.008234376,0.02123688,0.6091951,0.0003825052,0.00008126222,0.00003749651,0.0004119684,0.0002430989,0.3558247,0.0007702328,0.002900595,0.0006817157],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969414,0.001925493,0.00001878975,0.0003268127,0.00007396327,0.0002123681,0.0002114979,0.000006775959,0.0002829221],"genre_scores_gemma":[0.9980702,0.001067698,0.0002190605,0.0003977847,0.00005551633,0.00004490594,0.00007664715,0.00002353665,0.0000446812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6163324,"threshold_uncertainty_score":0.7318682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006743580355968832,"score_gpt":0.2761653726675962,"score_spread":0.2694217923116274,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}